Armando, a 71-year-old with an active lifestyle, was midway through a round of golf when a strange sensation crept into his ...

A population-based study revealed treatment patterns among patients starting chemotherapy as first-line therapy for ...

A new report dives into the evolving clinical trial landscape and transformative therapies changing lives for bladder cancer ...

Discover recent advancements in near-infrared fluorescence imaging that have revolutionised lymph node tracing in cancers ...

Some patients with low-grade Ta nonmuscle-invasive bladder cancer (LG Ta NMIBC) can experience recurrence after many years.

Two enzyme inhibitors join forces in reducing bladder cancer cell proliferation. n 1996, molecular biologist Kun Ping Lu, a ...

ImmunityBio will part with 10 employees this quarter. Last fall, it cut 31 employees. The moves come as the biotech works to advance Anktiva in non-small cell lung cancer.

A woman undergoing treatment for cancer took a dip in the Ganga river, hoping the auspicious occasion of Mauni Amavasya turns ...

Bladder cancer is one of the most common malignant tumors in urinary system, and the treatment faces huge challenges.

A combination therapy of two drugs — a statin and a protein inhibitor — may help suppress the creation and growth of tumors ...

A recent study finds that sequential gemcitabine/docetaxel treatment offers better outcomes than additional BCG therapy for ...

The Phase III trial builds on findings from prior findings that indicated Anktiva can restore T-cell function and improve ...